{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:51:41Z","timestamp":1784685101531,"version":"3.55.0"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1590\/s0100-879x2007000300009","type":"journal-article","created":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T13:08:01Z","timestamp":1173964081000},"page":"343-348","source":"Crossref","is-referenced-by-count":5,"title":["The combination of atorvastatin and ethanol is not more hepatotoxic to rats than the administration of each drug alone"],"prefix":"10.1590","volume":"40","author":[{"given":"D.T.","family":"Ito","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Molina","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Andriolo","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Borges","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00320.x","article-title":"Cascade genetic screening for familial hypercholesterolemia","volume":"66","author":"Leren TP","year":"2004","journal-title":"Clin Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9163","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1371\/journal.pmed.0020123","article-title":"National trends in statin use by coronary heart disease risk category","volume":"2","author":"Ma J","year":"2005","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1503\/cmaj.1041403","article-title":"Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect","volume":"172","author":"Zhou Z","year":"2005","journal-title":"CMAJ","ISSN":"https:\/\/id.crossref.org\/issn\/0820-3946","issn-type":"print"},{"key":"ref4","series-title":"IMS reports 8 percent constant dollar growth in 2002 audited global pharmaceutical sales to $400.6 billion (site on the internet): Fairfield (CT): IMS Health"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2165\/00003495-199753050-00011","article-title":"Atorvastatin: A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias","volume":"53","author":"Lea AP","year":"1997","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman KG","year":"2002","journal-title":"Am J Cardiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.20671","article-title":"Statins and hepatotoxicity: focus on patients with fatty liver","volume":"41","author":"Chalasani N","year":"2005","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak RC","year":"2002","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinte.158.6.577","article-title":"An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor","volume":"158","author":"Black DM","year":"1998","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0002-9149(01)01464-3","article-title":"Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin","volume":"87","author":"Downs JR","year":"2001","journal-title":"Am J Cardiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-8278(05)80103-5","article-title":"The recognition site for hepatic clearance of plasma kallikrein is on its heavy chain and is latent on prokallikrein","volume":"16","author":"Borges DR","year":"1992","journal-title":"J Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(99)00569-3","article-title":"Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin","volume":"353","author":"Nakad A","year":"1999","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(02)00092-2","article-title":"Acute cholestatic hepatitis after reinitiating treatment with atorvastatin","volume":"37","author":"Ridruejo E","year":"2002","journal-title":"J Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(05)75706-8","article-title":"Cholestatic liver dysfunction","volume":"354","author":"Wierzbicki AS","year":"1999","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2003.12.022","article-title":"Atorvastatin as a trigger of autoimmune hepatitis","volume":"40","author":"Pelli N","year":"2004","journal-title":"J Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0168-8278(03)00464-1","article-title":"Fatal liver failure with atorvastatin","volume":"39","author":"Perger L","year":"2003","journal-title":"J Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"69F","DOI":"10.1016\/j.amjcard.2005.06.028","article-title":"Safety of high-dose atorvastatin therapy","volume":"96","author":"Waters DD","year":"2005","journal-title":"Am J Cardiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001648-200109000-00017","article-title":"Lipid-lowering drugs and risk of myopathy: a population-based follow-up study","volume":"12","author":"Gaist D","year":"2001","journal-title":"Epidemiology","ISSN":"https:\/\/id.crossref.org\/issn\/1044-3983","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa022095","article-title":"Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men","volume":"348","author":"Mukamal KJ","year":"2003","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd J","year":"1995","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1161\/CIRCULATIONAHA.105.555482","article-title":"The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis","volume":"111","author":"Alsheikh-Ali AA","year":"2005","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa JC","year":"2005","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever PS","year":"2003","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"5","author":"Pedersen TR","year":"2004","journal-title":"1994. Atheroscler Suppl"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9149(03)00820-8","article-title":"Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients","volume":"92","author":"Newman CB","year":"2003","journal-title":"Am J Cardiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9149","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/archinte.163.6.688","article-title":"Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting","volume":"163","author":"Smith CC","year":"2003","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/0006-2952(85)90713-0","article-title":"Studies on the effect of chronic consumption of moderate amounts of ethanol on male rat hepatic microsomal drug-metabolizing activity","volume":"34","author":"Prasad JS","year":"1985","journal-title":"Biochem Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0006-2952","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v40n3\/6495.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T23:14:30Z","timestamp":1495754070000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2007000300009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0100-879X2007000300009"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2007000300009","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}